1. |
Ljubimov AV. Diabetic complications in the cornea[J]. Vision Res, 2017,139:138-152.DOI:10.1016/j.visres.2017.03.002.
|
2. |
Vieira-Potter VJ, Karamichos D, Lee DJ. Ocular complications of diabetes and therapeutic approaches[J/OL]. Biomed Res Int, 2016, 2016:3801570[2016-03-28] . https://dx.doi.org/10.1155/2016/3801570. DOI: 10.1155/2016/3801570.
|
3. |
Chen WL, Lin CT, Ko PS, et al. In vivo confocal microscopic findings of corneal wound healing after corneal epithelial debridement in diabetic vitrectomy[J]. Ophthalmology, 2009, 116(6): 1038-1047. DOI:10.1016/j.ophtha.2009.01.002.
|
4. |
Chen HF, Yeung L, Yang KJ, et al. Persistent corneal epithelial defect after pars plana vitrectomy[J]. Retina, 2016, 36(1): 148-155.DOI:10.1097/iae.0000000000000657.
|
5. |
Hayashi K, Berman M, Smith D, et al. Pathogenesis of corneal epithelial defects: role of plasminogen activator[J]. Curr Eye Res, 1991, 10(5): 381-398.
|
6. |
中华医学会眼科学分会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2014年)[J]. 中华眼科杂志, 2014, 50(11): 851-865.DOI:10.3760/cma.j.issn.0412-4081.2014.11.014.Chinese Ocular Fundus Diseases Society, Chinese Ophthalmological Society, Chinese Medical Association. Guidelines for clinical diagnosis and treatment of diabetic retinopathy in China[J].Chin J Ophthalmol, 2014, 50(11):851-865. DOI:10.3760/cma.j.issn.0412-4081.2014.11.014.
|
7. |
中华医学会眼科学分会角膜病学组. 我国角膜上皮损伤临床诊治专家共识(2016年)[J]. 中华眼科杂志, 2016, 52(9): 644-648.DOI:10.3760/cma.j.issn.0412-4081.2016.09.002.Keratonosus Diseases Society, Chinese Ophthalmological Society, Chinese Medical Aassociation. Clinical diagnosis and expert consensus 2016 corneal epithelium damage in our country[J].Chin J Ophthalmol, 2016, 52(9): 644-648. DOI:10.3760/cma.j.issn.0412-4081.2016.09002.
|
8. |
Hiraoka M, Amano S, Oshika T, et al. Factors contributing to corneal complications after vitrectomy in diabetic patients[J]. Jpn J Ophthalmol, 2001, 45(5): 492-495.
|
9. |
Matsumura T, Takamura Y, Tomomatsu T, et al. Changes in matrix metalloproteinases in diabetes patients' tears after vitrectomy and the relationship with corneal epithelial disorder[J]. Invest Ophthalmol Vis Sci, 2015, 56(6): 3559-3564.DOI:10.1167/iovs.15-16489.
|
10. |
Zhang X, Zhao L, Deng S, et al. Dry eye syndrome in patients with diabetes mellitus: prevalence, etiology, and clinical character-istics[J/OL]. J Ophthalmol, 2016, 2016: 8201053[2016/05/24]. https://dx.doi.org/10.1155/2016/8201053. DOI:10.1155/2016/8201053.
|
11. |
Hayashi Y, Toshida H, Matsuzaki Y, et al. Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes[J]. Int Med Case Rep J, 2016, 9: 113-116.DOI:10.2147/imcrj.s103299.
|
12. |
梁庆丰, 董喆, 王宁利. 睑板腺功能障碍患者白内障围手术期需关注的问题及对策[J]. 中华眼科杂志, 2014, 50(4): 244-246.DOI:10.3760/cma.j.issn.0412-4081.2014.04.002.Ling QF, Dong Z, Wang NL. Perioperative ocular surface evaluation and management in meibomian gland dysfunction patients undergoing cataract surgery[J]. Chin J Ophthalmol, 2014, 50(4):244-246. 1111111155555555j.issn.04124081. 2014. 04. 002.
|
13. |
Zheng T, Yang J, Xu J, et al. Near-term analysis of corneal epithelial thickness after cataract surgery and its correlation with epithelial cell changes and visual acuity[J]. J Cataract Refract Surg, 2016, 42(3): 420-426. DOI:10.1016/j.jcrs.2015.09.029.
|
14. |
Laurell CG, Zetterstrom C. Inflammation and blood-aqueous barrier disruption[J]. J Cataract Refract Surg, 2000, 26(3): 306-307.
|
15. |
Lahey JM, Francis RR, Kearney JJ. Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy: a series of 223 cases[J]. Ophthalmology, 2003, 110(7): 1335-1339.DOI:10.1016/s0161-6420(03)00454-8.
|
16. |
Koushan K, Mikhail M, Beattie A, et al. Corneal endothelial cell loss after pars plana vitrectomy and combined phacoemulsification-vitrectomy surgeries[J]. Can J Ophthalmol, 2017, 52(1): 4-8. DOI:10.1016/j.jcjo.2016.06.001.
|
17. |
Al-Hinai AS. Corneal epithelial defect after pars plana vitrectomy[J]. Oman J Ophthalmol, 2017, 10(3): 162-166. DOI:10.4103/ojo.OJO_122_2016.
|
18. |
Inoue K, Okugawa K, Kato S, et al. Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy[J]. J Glaucoma, 2003, 12(6): 480-485.
|
19. |
Fraunfelder FW. Corneal toxicity from topical ocular and systemic medications[J]. Cornea, 2006, 25(10): 1133-1138.DOI:10.1097/01.ico.0000240084.27663.fd.
|
20. |
Yulek F, Ozdek S, Gurelik G, et al. Effect of topical steroids on corneal epithelial healing after vitreoretinal surgery[J]. Acta Ophthalmol Scand, 2006, 84(3): 319-322. DOI:10.1111/j.1600-0420.2005.00632.x.
|
21. |
Boscia F, Cardascia N, Sborgia L, et al. Evaluation of corneal damage by combined phacoemulsification and passive efflux of silicone oil in vitrectomized eyes[J]. J Cataract Refract Surg, 2003, 29(6): 1120-1126.
|
22. |
Friberg TR, Ohji M, Scherer JJ, et al. Frequency of epithelial debridement during diabetic vitrectomy[J]. Am J Ophthalmol, 2003, 135(4): 553-554.
|
23. |
Perry HD, Foulks GN, Thoft RA, et al. Corneal complications after closed vitrectomy through the pars plana[J]. Arch Ophthalmol, 1978, 96(8): 1401-1403.
|
24. |
Chung H, Tolentino FI, Cajita VN, et al. Reevaluation of corneal complications after closed vitrectomy[J]. Arch Ophthalmol, 1988, 106(7): 916-919.
|
25. |
Khanam PA, Hoque S, Begum T, et al. Microvascular complications and their associated risk factors in type 2 diabetes mellitus[J]. Diabetes Metab Syndr, 2017,11:577-581. DOI:10.1016/j.dsx.2017.04.007.
|
26. |
Ozdemir M, Buyukbese MA, Cetinkaya A, et al. Risk factors for ocular surface disorders in patients with diabetes mellitus[J]. Diabetes Res Clin Pract, 2003, 59(3): 195-199.
|